SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The 6-K discloses the resignation of UHY Malaysia PLT as independent auditor effective June 29, 2026, and the appointment of SFAI Malaysia PLT as the new auditor on July 3, 2026. The filing explicitly addresses Item 304 of Regulation S-K, confirming no disagreements or reportable events preceded the change. This is a clear auditor change event material to investors assessing the registrant's financial reporting oversight.
View raw filing on EDGAR →The filing discloses two material operational developments under Item 8.01: (1) a strategic partnership between the AVO brand and the largest college bookstore chain (1,000+ locations), with AVO assuming lululemon's prime retail space; and (2) forward guidance for Q3 2026 projecting $8.5–$11.0 million in revenue (300–500% YoY growth) and positive net income, driven by collegiate expansion (1 to 18 universities) and a landmark government contract. While the guidance contains forward-looking financial projections, the core disclosure centers on operational partnerships and business expansion strategy rather than a formal earnings release or financial results. The partnership and government contract represent material strategic milestones affecting the registrant's business trajectory.
View raw filing on EDGAR →The filing discloses an unregistered private placement of 8,000,000 shares of common stock to Sinco International Investments, Inc. for $25,000 cash under Section 4(a)(2) and Rule 506(b), explicitly covered under Item 3.02 (Unregistered Sales of Equity Securities). This represents a highly dilutive issuance at a minimal valuation ($0.003125 per share), which would materially affect shareholder equity and voting power.
View raw filing on EDGAR →The Company entered into an Equity Transfer Agreement on July 1, 2026, to sell 100% of Mahaotiaodong Information Technology Company (a wholly owned subsidiary holding Code Beating, which provided SMS services in China) to an unrelated third party for US$100. This is a disposition of a material subsidiary, constituting a change of control or divestiture of a business unit. Although the target had ceased operations and carried significant losses (US$1.56 million), the transaction represents a material M&A activity requiring disclosure under Item 1.02 or 2.01 equivalent.
View raw filing on EDGAR →The filing discloses a Nasdaq Hearings Panel determination to delist Bayview Acquisition Corp's securities effective July 7, 2026, due to failure to complete its business combination with Oabay by the June 19, 2026 deadline. This is a direct delisting notice under Item 3.01, representing a terminal loss of exchange listing and a material adverse event for the registrant and its shareholders.
View raw filing on EDGAR →The filing discloses an Equity Purchase Agreement with Hudson Global Ventures, LLC granting the investor the right to purchase up to $15,000,000 of common stock through put notices, plus a warrant to purchase 1,000,000 shares at $0.50 per share. Item 3.02 explicitly confirms unregistered sales of equity securities under Section 4(a)(2) and Regulation D. This is a classic dilutive private placement with a PIPE-like structure, material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →Bone Biologics priced a private offering on July 7, 2026, selling pre-funded warrants and Series F and G warrants to purchase 2,112,677 shares of common stock at a combined purchase price of $1.419 per unit, generating approximately $2.7 million in net proceeds with potential additional gross proceeds of approximately $6 million upon full exercise of the warrants. The securities were issued without registration under Section 4(a)(2) of the Securities Act as a private placement to an accredited investor.
View raw filing on EDGAR →The filing discloses the Board's appointment of Alisa Bowen as Chief Executive Officer of FuboTV, effective July 10, 2026, succeeding co-founder David Gandler. While Gandler's departure is also mentioned, the principal disclosed action centers on the appointment of a new CEO—a veteran media executive with extensive experience at Disney, News Corporation, and other major media organizations. This is a material executive leadership transition at a public company.
View raw filing on EDGAR →The filing discloses Roadzen's entry into a definitive Share Purchase Agreement on July 3, 2026, to acquire Riverside International Holdings Ltd, a European managing general agent specializing in short-term car rental insurance. The transaction is valued at approximately £12 million (approximately $15 million USD) with 50% payable at closing and 50% structured as a three-year earn-out. Item 1.01 explicitly covers "Entry into a Material Definitive Agreement," and the acquisition is material to investors as it represents a significant strategic expansion into the European car rental insurance market with an established, profitable platform generating $18–20 million in annual revenue.
View raw filing on EDGAR →This disclosure announces a 12-for-1 share consolidation approved by the board on June 6, 2026, effective July 14, 2026. The consolidation is a governance and capital structure action undertaken to maintain Nasdaq listing compliance under Rule 5550(a)(2). While not a named governance type (such as an executive appointment or auditor change), it is clearly a material governance/corporate action affecting all shareholders' holdings and the company's continued listing status.
View raw filing on EDGAR →The filing discloses entry into a General Agreement for Omnibus Credit Lines with CTBC Bank on July 3, 2026, establishing a short-term unsecured credit facility of approximately US$1.94 million at 2.5% per annum, maturing September 30, 2026. This is a creation of a direct financial obligation under Item 2.03, fitting the debt_issuance category as a new credit facility arrangement.
View raw filing on EDGAR →The filing discloses under Item 4.01 that on July 9, 2026, the Audit Committee dismissed BCRG as the independent registered public accounting firm and appointed Simon & Edward LLP as the new auditor, effective after S&E acquired BCRG's attest business on June 15, 2026. This is a clear auditor change event. The materiality is heightened by the fact that BCRG's prior audit reports included an explanatory paragraph indicating substantial doubt about the Trust's ability to continue as a going concern, making the auditor transition particularly significant to investors.
View raw filing on EDGAR →The filing discloses a press release issued on July 9, 2026, announcing the Fund's second quarter 2026 private loan portfolio activity, including new commitments of $74.4 million and funded investments of $62.2 million, along with portfolio composition details as of June 30, 2026. This is a periodic financial and operational update typical of earnings releases filed under Item 2.02, disclosing material portfolio metrics and investment activity that would inform investors about the Fund's financial condition and operational performance.
View raw filing on EDGAR →Nurix issued a press release on July 9, 2026, announcing financial results for the fiscal quarter ended May 31, 2026, including revenue of $9.0 million, R&D expenses of $87.7 million, and a net loss of $89.5 million ($0.81 per share). The disclosure is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. While the press release also highlights the Roche collaboration agreement, the primary disclosure is the quarterly financial results.
View raw filing on EDGAR →Cosan discloses execution of an agreement for consensual segregation of land assets in Mato Grosso and new purchase and sale agreements with SLC Agrícola, Bom Futuro, and Alexandre Jacques Bottan. The transaction involves a total value of R$1.85 billion (approximately R$586 million attributable to Cosan's indirect interest) with closing expected by October 30, 2026. This constitutes a material disposition of assets meeting the definition of ma_activity under Item 1.02 or 2.01 of the 8-K taxonomy.
View raw filing on EDGAR →News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transactions totaling approximately $229.3 million in Class A and Class B stock purchases on July 8–9, 2026. While technically a capital allocation rather than a dividend, share repurchases are economically equivalent to distributions and are classified under the dividend_distribution category as a return of capital to shareholders. The filing is material because it represents significant ongoing execution of a shareholder-value-enhancing program and provides transparency on capital deployment.
View raw filing on EDGAR →News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transaction details including 9.1 million Class A shares and 66,163 Class B shares purchased on July 9-10, 2026 for approximately $231 million in aggregate consideration. Share repurchases are a form of capital return to shareholders and constitute a material capital allocation decision affecting shareholder value.
View raw filing on EDGAR →Dr. Reddy's discloses that certain batches of semaglutide (a key metabolic therapy product) were found out-of-specification due to an active pharmaceutical ingredient (API) issue, requiring investigation and causing commercial supply delays. While no patient safety impact is claimed, the disclosure of a product quality issue affecting a major commercial product with delayed supplies is a material operational event affecting the company's ability to fulfill market demand. This does not fit the specific categories of material_impairment, restatement, or cybersecurity_incident, but represents a material operational/quality disruption requiring disclosure under SEBI Regulation 30.
View raw filing on EDGAR →Bloom Energy is responding to a published report by Hunterbrook Media (a short-seller outlet) that made claims about the company's financial results, accounting practices, and supply chain dependencies. The company categorically rejects the allegations as "false and misleading" and defends the integrity of its audited financial statements. While this is a material event affecting investor perception and confidence in the company's disclosures, it does not fit neatly into specific 8-K categories—it is neither a restatement (no non-reliance on prior statements), nor litigation (no lawsuit disclosed), nor a specific operational or financial event. The disclosure is material because it addresses serious allegations about accounting accuracy and supply chain risk that would affect a reasonable investor's assessment, but the event type itself—a public response to short-seller allegations—falls outside the defined taxonomy.
View raw filing on EDGAR →RCI issued a press release on July 9, 2026 announcing sales results for the third fiscal quarter ended June 30, 2026, disclosing total club and sports bar sales of $73.3 million with a 4.0% increase year-over-year. This is a periodic financial results disclosure typical of earnings releases, filed under Item 2.02 and furnished as Exhibit 99.1, which would materially inform investors about the company's operational performance.
View raw filing on EDGAR →Aircastle Limited announced first quarter 2026 financial results on July 9, 2026, disclosing total revenues of $236 million, net income of $34 million, and adjusted EBITDA of $208 million. The disclosure is presented as a formal earnings release (Exhibit 99.1) furnished under Item 2.02 (Results of Operations and Financial Condition), which is the standard vehicle for quarterly earnings announcements. The filing includes consolidated financial statements (balance sheet, income statement, and cash flow statement) and reconciliations of non-GAAP measures, all characteristic of a quarterly earnings release.
View raw filing on EDGAR →Emmanuel Babeau, the Group Chief Financial Officer, is departing his executive role effective August 1, 2026, though he will remain employed as Strategic Advisor through March 31, 2027. The disclosure centers on his separation from the CFO position and the associated severance and compensation arrangements, including a lump-sum severance payment of CHF 1,260,012, continued base salary through the separation date, and full vesting of equity awards. While the filing also mentions Massimo Andolina's appointment as replacement CFO, the primary focus and substance of the disclosure is Babeau's departure and the material separation terms.
View raw filing on EDGAR →The filing discloses that Fathom Holdings received a Nasdaq non-compliance notice on April 10, 2026 for failing the minimum $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2), but subsequently regained compliance by July 6, 2026 when the closing bid price remained at or above $1.00 for 10 consecutive business days. This is a delisting risk event—the company faced potential delisting but has now cured the deficiency. The disclosure of the initial non-compliance notice and subsequent cure is material to investors assessing the company's listing status and financial condition.
View raw filing on EDGAR →Haiyan Song was appointed as a new Class III director effective July 9, 2026, bringing cybersecurity and software expertise to strengthen the Board's capabilities. The appointment was accompanied by related board transitions including Greg Nixon's resignation as preferred stock director and Nathaniel Fick's transition from Class III to preferred stock director.
View raw filing on EDGAR →MarketWise issued a press release on July 9, 2026 announcing preliminary selected unaudited financial and operational results for Q2 2026, including billings of $91 million (56% YoY growth), paid subscriber metrics, and raised FY 2026 billings guidance by 10% to $330 million. This is a classic earnings release disclosure under Item 2.02, furnished as Exhibit 99.1, providing investors with preliminary quarterly financial results and forward guidance.
View raw filing on EDGAR →Ares Management disclosed preliminary realized net performance income for Q2 2026 expected to exceed $50 million, compared to $16 million in the prior-year quarter, representing a material increase of over 200%. The disclosure was made through Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure), with the latter furnishing the preliminary earnings announcement.
View raw filing on EDGAR →DXP Enterprises entered into a Second Amended and Restated Loan and Security Agreement on July 2, 2026, increasing its asset-based revolving credit facility from $185 million to $225 million—a $40 million increase. This amendment expands the company's borrowing capacity and is intended to support growth and acquisition strategy.
View raw filing on EDGAR →Barnes & Noble Education issued a press release on July 9, 2026 announcing full-year fiscal 2026 financial results for the period ended May 2, 2026. The disclosure includes comprehensive financial metrics: $1.715 billion in revenue (6.5% growth), $16.9 million net income (vs. prior-year loss of $65.8 million), and $76.5 million Adjusted EBITDA (28.8% increase). The press release also provides fiscal 2027 guidance and announces an inaugural quarterly dividend of $0.08 per share. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →AstraZeneca announced that its Phase III CARDIO-TTRansform trial for Wainua (eplontersen) in transthyretin-mediated amyloid cardiomyopathy "did not meet the primary efficacy endpoint" of reducing cardiovascular mortality and recurrent CV events versus placebo. This is a material clinical trial failure for a drug in late-stage development affecting a significant patient population (300,000–500,000 worldwide). While not a discrete event type like M&A or restatement, the failure of a major Phase III program is a material operational/clinical development outcome that would affect investor assessment of the company's pipeline and near-term revenue prospects.
View raw filing on EDGAR →This is a major holdings notification (Standard Form TR-1) disclosing that The Capital Group Companies, Inc. and Capital Research and Management Company crossed the 16.00% voting-rights threshold in Ryanair Holdings PLC on 07 July 2026, increasing from 15.07% to 16.08%. This is a material change in share ownership structure that would affect investor assessment of control and influence, but it is not a shareholder vote result—it is a passive disclosure of a threshold crossing by an existing shareholder.
View raw filing on EDGAR →GSK announced the appointment of Roy Jakobs as a Non-Executive Director effective 13 July 2026. The disclosure details his background as CEO of Royal Philips, his independence status, compensation terms (£122,258 annual fee), and share ownership requirements. This is a clear executive appointment to the Board, material to investors assessing governance and leadership composition.
View raw filing on EDGAR →The Federal Home Loan Bank of New York discloses the issuance of consolidated obligations (bonds and discount notes) totaling approximately $6 billion in principal amount across four separate debt securities issued on trade date 7/7/2026. Schedule A details specific bond issuances with varying maturity dates, coupon structures, and call provisions. This constitutes creation of direct financial obligations under Item 2.03 and is material to the Bank's capital structure and funding activities.
View raw filing on EDGAR →Onfolio Holdings received a written notice from NASDAQ on July 2, 2026, stating non-compliance with NASDAQ Listing Rule 5550(a)(2) due to closing bid price below $1.00 per share for 30 consecutive business days. The company has 180 calendar days to regain compliance or faces potential delisting. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →David Kratochvil was appointed as Chief Executive Officer on July 2, 2026, following the resignation of Mike Schmidt. The appointment includes a new employment agreement with a base salary of $180,000 and 100,000 stock units.
View raw filing on EDGAR →The Company disclosed a prior Nasdaq listing compliance matter under Listing Rule 5550(a)(2) regarding the Minimum Bid Price Requirement, with a non-compliance notice issued on February 20, 2026 and a 180-day cure period. The Company regained compliance as of July 2, 2026, though cautionary language indicates no assurance of maintaining future compliance.
View raw filing on EDGAR →VersaBank announced that its US subsidiary has entered into an agreement with an ECN Capital subsidiary to utilize VersaBank's Structured Receivable Program (SRP), with expected contributions of at least US$300 million annually and potential growth beyond US$500 million per year. This represents a material operational and strategic partnership expansion in VersaBank's core SRP business line, though it does not constitute a discrete M&A transaction, debt issuance, or other specifically-named event type. The disclosure emphasizes the program's growth trajectory and competitive positioning in the point-of-sale financing market.
View raw filing on EDGAR →EquipmentShare.com Inc released an update on financial performance for the quarter ended June 30, 2026, and raised full-year 2026 financial guidance, including increased rental segment revenue growth outlook from 29% to 33%.
View raw filing on EDGAR →The Simply Good Foods Company disclosed its fiscal third quarter 2026 financial results on July 9, 2026, including net sales of $357.0 million (down 6.3% YoY), a net loss of $52.0 million (versus prior year net income of $41.1 million), and material impairment charges of $82.0 million. The press release (Exhibit 99.1) provides detailed quarterly and year-to-date results, updated full-year guidance, and forward-looking statements. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →Austin Kaplicer, Chief Accounting Officer and principal accounting officer, resigned effective August 6, 2026. While the filing also discloses the promotion of Scott Jakalow to CAO and the designation of Julie Hoarau as principal accounting officer, the principal disclosed action centers on Kaplicer's departure from a key financial reporting role. The resignation is material to investors as it affects the registrant's accounting leadership, though the company explicitly states it was not due to disagreement on financial matters.
View raw filing on EDGAR →FirstSun Capital Bancorp disclosed Q2 2026 financial results, including material adverse credit events: a $22.0 million charge-off on a $23.6 million asset-based loan involving alleged borrower fraud and a $12.9 million charge-off on a $16.0 million commercial loan due to borrower deterioration. The company updated its full-year 2026 credit outlook, projecting net charge-offs to average loans in the high 50s basis points and allowance for credit losses in the mid-140s to 150s basis points.
View raw filing on EDGAR →NYSE American has accepted Splash Beverage's compliance plan to regain compliance with shareholders' equity requirements, granting a compliance period through January 29, 2027. If the Company fails to regain compliance by that date or does not make progress consistent with the plan, NYSE American may initiate delisting proceedings.
View raw filing on EDGAR →The disclosure announces a $100 million stock repurchase program authorized by the Board on June 8, 2026, with 641,342 shares repurchased to date at an average price of $11.27. Stock repurchase programs constitute a return of capital to shareholders and fall within the dividend_distribution category, which explicitly includes "share-repurchase programs." This is material to investors as it signals capital allocation policy and affects share count and EPS.
View raw filing on EDGAR →Rackspace Technology issued a press release on July 9, 2026 announcing preliminary financial results for Q2 2026 (quarter ended June 30, 2026) and updating its full-year FY26 outlook with material downward revisions ($150M revenue reduction, $20M EBITDA reduction), including detailed preliminary GAAP and non-GAAP financial metrics.
View raw filing on EDGAR →Rackspace entered into an at-the-market (ATM) equity distribution agreement with Goldman Sachs on July 9, 2026, authorizing the sale of up to $250 million in common stock to accelerate Enterprise AI Growth and fund the company's next phase of growth.
View raw filing on EDGAR →Rackspace amended its Accounts Receivable Securitization Facility, creating a direct financial obligation that affects the company's capital structure and liquidity position.
View raw filing on EDGAR →This is an announcement of an upcoming earnings release and conference call for Lightspeed's fiscal first quarter 2027 financial results, scheduled for July 30, 2026. The document explicitly states the company "will report first quarter 2027 financial results" and provides details for the earnings call. While the actual results are not disclosed in this exhibit, the announcement of the earnings release event itself is material to investors and is the substance of the disclosure.
View raw filing on EDGAR →Enovix announced the appointment of Dr. Michael Vyvoda as Chief Operating Officer, effective July 29, 2026. The disclosure details his background, compensation package ($440,000 base salary plus 60% bonus target and $4.1 million in RSUs), and severance terms. While the filing includes compensatory arrangements, the principal disclosed action is the appointment of a named executive officer to a C-suite role, making exec_appointment the most salient classification.
View raw filing on EDGAR →Innovative Eyewear entered into an inducement letter agreement whereby existing warrant holders exercised 2,200,544 warrants at a reduced price ($1.35 vs. original $2.60), generating approximately $3.0 million in gross proceeds. In consideration, the Company issued 6,601,632 new unregistered Series J warrants in a private placement, representing a classic dilutive warrant-for-warrant exchange with potential additional proceeds of ~$7.25 million if fully exercised and creating significant dilution to existing shareholders.
View raw filing on EDGAR →RF Acquisition Corp III entered into a Business Combination Agreement with HCC Healthcare on July 9, 2026, whereby HCC Healthcare will become a publicly traded company on Nasdaq with an approximately $500 million equity valuation, with closing expected in Q4 2026.
View raw filing on EDGAR →The Trust disclosed Q1-2026 consolidated financial statements of Penney Intermediate Holdings LLC for the three months ended May 2, 2026, including unaudited financial statements showing a net loss of $65 million, balance sheets, cash flow statements, and detailed Master Lease JCP store performance metrics.
View raw filing on EDGAR →